Subcutaneous herceptin therapy.

@article{ODonoghue2013SubcutaneousHT,
  title={Subcutaneous herceptin therapy.},
  author={Niamh O'Donoghue and Keith Ian Quintyne and Bernie Woulfe and Rajnish Gupta and Seamus O'Reilly},
  journal={Journal of clinical pharmacology},
  year={2013},
  volume={53 12},
  pages={1341-2}
}
In a recent issue of the Journal of Clinical Pharmacology, we noted with interest the paper by Wynne et al which compared subcutaneous and intravenous administration of trastuzumab in a Phase l/lb trial in healthy male volunteers and patients with HER‐2 positive breast cancer. As discussed in the paper, the potential benefits of such a formulation of… CONTINUE READING